A world of possibilities
Navigating life sciences and medtech to the extraordinary—driven by creativity, curiosity, and the courage to build a fulfilling journey.
-
BAFF Specific Antibodies
Publication Number: WO/2025/125137Applicant: GlaxoSmithKline Intellectual Property Development LimitedFiling Date: December 9, 2024 (published mid-2025)Publication Date: June 19, 2025 What the Patent Covers This international patent application focuses on antibodies that specifically bind B-cell activating factor…
-
Modulation of Huntingtin Expression
Assignee: Ionis Pharmaceuticals, Inc.Patent Number: 12,297,431Filing Date: (priority filing in 2022)Patent Issued: May 13, 2025Inventors: Gene Hang (et al.) What It Covers This patent protects compositions and methods for reducing the expression of the huntingtin…
-
Conjugates of Phenylalanine Ammonia‑Lyase and POEGMA and Methods for Their Use
Assignee: BioMarin Pharmaceutical Inc.Publication Number: US 20250161466 A1Filed: November 15, 2024Publication Date: May 22, 2025 What It Covers This published patent application discloses novel therapeutic conjugates consisting of: The application further discloses pharmaceutical compositions of these POEGMA‑PAL conjugates, methods of reducing…
BioTech IP Review 